Literature DB >> 28839631

Upper gastrointestinal cancer in its early stages is predominantly asymptomatic.

James W Berrill1, Jeff K Turner1, Jo J Hurley1, Gillian Swift1, Sunil Dolwani1, John T Green1.   

Abstract

BACKGROUND: Current guidelines for urgent endoscopic investigation of dyspepsia are based on alarm features and age criteria. However, there is concern that this type of guideline may delay the diagnosis of upper gastrointestinal (GI) cancer.
OBJECTIVE: To evaluate the timescale of symptoms in upper GI cancer, determining whether patients experience dyspepsia before developing alarm features, and hence whether the current guidelines may delay diagnosis.
METHOD: A prospective study of patients diagnosed with upper GI cancer between May 2004 and January 2007. A structured interview was performed directly after endoscopic diagnosis regarding the nature and duration of symptoms.
RESULTS: Alarm features were present in 56 of the 60 patients interviewed. Only eight patients reported dyspepsia before developing their alarm feature; three of these had complained of dyspepsia for >10 years, one reported dyspepsia preceding the alarm feature by 18 months and in four patients dyspepsia preceded the alarm feature by ≤8 weeks. Preceding dyspepsia did not cause significant delay in referral for endoscopy (p=0.670), or affect tumour stage at diagnosis (p=0.436) or length of survival (p=0.325).
CONCLUSION: It is rare for patients with upper GI cancer to experience significant dyspepsia before the onset of their alarm symptoms, therefore limiting the prospect of an earlier diagnosis. Early upper GI cancer is largely asymptomatic, and guidelines should limit the availability of open-access gastroscopy in simple dyspepsia. Increased awareness of the need to urgently investigate patients with concurrent anaemia or weight loss is required.

Entities:  

Year:  2011        PMID: 28839631      PMCID: PMC5517248          DOI: 10.1136/flgastro-2011-100026

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  22 in total

1.  Gastric cancer in patients with benign dyspepsia.

Authors:  K E McColl; J Kidd; D Gillen
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Does endoscopy diagnose early gastrointestinal cancer in patients with uncomplicated dyspepsia?

Authors:  N Sundar; V Muraleedharan; J Pandit; J T Green; R Crimmins; G L Swift
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

3.  Predictive value of alarm features in a rapid access upper gastrointestinal cancer service.

Authors:  N Kapoor; A Bassi; R Sturgess; K Bodger
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

4.  A survey of dyspepsia in Great Britain.

Authors:  J G Penston; R E Pounder
Journal:  Aliment Pharmacol Ther       Date:  1996-02       Impact factor: 8.171

5.  Missing gastric cancer in dyspepsia.

Authors:  N Schmidt; U Peitz; H Lippert; P Malfertheiner
Journal:  Aliment Pharmacol Ther       Date:  2005-04-01       Impact factor: 8.171

6.  Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked.

Authors:  D J Bowrey; S M Griffin; J Wayman; D Karat; N Hayes; S A Raimes
Journal:  Surg Endosc       Date:  2006-10-05       Impact factor: 4.584

7.  Prognostic significance of alarm symptoms in patients with gastric cancer.

Authors:  M R Stephens; W G Lewis; S White; G R J C Blackshaw; P Edwards; J D Barry; M C Allison
Journal:  Br J Surg       Date:  2005-07       Impact factor: 6.939

8.  Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia.

Authors:  N P Breslin; A B Thomson; R J Bailey; P K Blustein; J Meddings; E Lalor; G M VanRosendaal; M J Verhoef; L R Sutherland
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

9.  Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?

Authors:  N Pandeya; P M Webb; S Sadeghi; A C Green; D C Whiteman
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

10.  Early gastric cancer: 46 cases treated in one surgical department.

Authors:  H M Sue-Ling; I Martin; J Griffith; D C Ward; P Quirke; M F Dixon; A T Axon; M J McMahon; D Johnston
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

View more
  1 in total

1.  The future developments in upper GI cancer.

Authors:  Hugh Barr; Max Almond
Journal:  Frontline Gastroenterol       Date:  2012-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.